Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

    Results: 6

    1.

    Safety and complications reporting update on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique.

    Centeno CJ, Schultz JR, Cheever M, Freeman M, Faulkner S, Robinson B, Hanson R.

    Curr Stem Cell Res Ther. 2011 Dec;6(4):368-78.

    PMID:
    22023622
    [PubMed - indexed for MEDLINE]
    2.

    Osteoblastic differentiation of human and equine adult bone marrow-derived mesenchymal stem cells when BMP-2 or BMP-7 homodimer genetic modification is compared to BMP-2/7 heterodimer genetic modification in the presence and absence of dexamethasone.

    Carpenter RS, Goodrich LR, Frisbie DD, Kisiday JD, Carbone B, McIlwraith CW, Centeno CJ, Hidaka C.

    J Orthop Res. 2010 Oct;28(10):1330-7. doi: 10.1002/jor.21126.

    PMID:
    20309952
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    3.

    Safety and complications reporting on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique.

    Centeno CJ, Schultz JR, Cheever M, Robinson B, Freeman M, Marasco W.

    Curr Stem Cell Res Ther. 2010 Mar;5(1):81-93.

    PMID:
    19951252
    [PubMed - indexed for MEDLINE]
    4.

    Regeneration of meniscus cartilage in a knee treated with percutaneously implanted autologous mesenchymal stem cells.

    Centeno CJ, Busse D, Kisiday J, Keohan C, Freeman M, Karli D.

    Med Hypotheses. 2008 Dec;71(6):900-8. doi: 10.1016/j.mehy.2008.06.042. Epub 2008 Sep 10.

    PMID:
    18786777
    [PubMed - indexed for MEDLINE]
    5.

    Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells.

    Centeno CJ, Busse D, Kisiday J, Keohan C, Freeman M, Karli D.

    Pain Physician. 2008 May-Jun;11(3):343-53.

    PMID:
    18523506
    [PubMed - indexed for MEDLINE]
    Free Article
    6.

    Phase I and pharmacokinetic study of gemcitabine administered at fixed-dose rate, combined with docetaxel/melphalan/carboplatin, with autologous hematopoietic progenitor-cell support, in patients with advanced refractory tumors.

    Nieto Y, Aldaz A, Rifón J, Pérez-Calvo J, Zafra A, Zufia L, Viúdez A, Viteri S, Aramendía JM, Aristu J, Centeno C, Moreno M, Sayar O, Hernández M.

    Biol Blood Marrow Transplant. 2007 Nov;13(11):1324-37. Epub 2007 Sep 7.

    PMID:
    17950919
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Search details

      See more...

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk